Home
SLRN
SLRN News

Latest ACELYRIN INC. (SLRN) News on July 8, 2024

Here's Why We're Watching Acelyrin's (NASDAQ:SLRN) Cash Burn Situation

Simply Wall St.

4 days ago

Here's Why We're Watching Acelyrin's (NASDAQ:SLRN) Cash Burn Situation

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a month ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

a month ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

a month ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

a month ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

a month ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Simply Wall St.

a month ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Simply Wall St.

a month ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

AFP

a month ago

Seoul resumes loudspeaker propaganda against North

ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024

GlobeNewswire

a month ago

ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024

ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024

GlobeNewswire

a month ago

ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024

ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones

GlobeNewswire

2 months ago

ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones

ACELYRIN, INC. Announces Leadership Transition

GlobeNewswire

2 months ago

ACELYRIN, INC. Announces Leadership Transition

ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024

GlobeNewswire

2 months ago

ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024

Acelyrin Insiders Placed Bullish Bets Worth US$2.65m

Simply Wall St.

3 months ago

Acelyrin Insiders Placed Bullish Bets Worth US$2.65m

ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights

GlobeNewswire

3 months ago

ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

GlobeNewswire

3 months ago

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease

GlobeNewswire

4 months ago

ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease

ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

GlobeNewswire

4 months ago

ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis

ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients

GlobeNewswire

4 months ago

ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients

ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications

GlobeNewswire

5 months ago

ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications

Baldinger: How 49ers HC Kyle Shanahan creates numbers advantage for McCaffrey in run game

NFL Highlights

5 months ago

Baldinger: How 49ers HC Kyle Shanahan creates numbers advantage for McCaffrey in run game

SunCoke Energy, Inc. (NYSE:SXC) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

SunCoke Energy, Inc. (NYSE:SXC) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 LendingClub Corp Earnings Call

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 01/31/2024

LendingClub (LC) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

LendingClub (LC) Reports Q4 Earnings: What Key Metrics Have to Say

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.

5 months ago

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Monro (NASDAQ:MNRO) Misses Q3 Revenue Estimates

StockStory

5 months ago

Monro (NASDAQ:MNRO) Misses Q3 Revenue Estimates

HCI Group Takes Strategic Steps to Better Position Company for Future Opportunities

GlobeNewswire

6 months ago

HCI Group Takes Strategic Steps to Better Position Company for Future Opportunities

Associated Press Finance

6 months ago

OceanFirst: Q4 Earnings Snapshot

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

GlobeNewswire

6 months ago

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

Associated Capital Reports Estimated Fourth Quarter and Full Year Results

GlobeNewswire

6 months ago

Associated Capital Reports Estimated Fourth Quarter and Full Year Results

Green Plains Inc. Completes Acquisition of Green Plains Partners LP

Business Wire

6 months ago

Green Plains Inc. Completes Acquisition of Green Plains Partners LP

NETSTREIT Corp. Announces Launch of Public Offering of Common Stock

Business Wire

6 months ago

NETSTREIT Corp. Announces Launch of Public Offering of Common Stock

GlobeNewswire

6 months ago

iHeartMedia and Magnite Unify Access to Broadcast and Digital Audio, Providing Advertisers with a Direct Path to Premium Inventory

ECARX Announces Board Changes

GlobeNewswire

6 months ago

ECARX Announces Board Changes

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Zacks

6 months ago

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Magnite, Inc.'s (NASDAQ:MGNI) recent 6.4% pullback adds to one-year year losses, institutional owners may take drastic measures

Simply Wall St.

6 months ago

Magnite, Inc.'s (NASDAQ:MGNI) recent 6.4% pullback adds to one-year year losses, institutional owners may take drastic measures

BioCryst Pharmaceuticals (NASDAQ:BCRX) investors are sitting on a loss of 48% if they invested a year ago

Simply Wall St.

6 months ago

BioCryst Pharmaceuticals (NASDAQ:BCRX) investors are sitting on a loss of 48% if they invested a year ago

Estimating The Intrinsic Value Of Ramaco Resources, Inc. (NASDAQ:METC)

Simply Wall St.

6 months ago

Estimating The Intrinsic Value Of Ramaco Resources, Inc. (NASDAQ:METC)

Are Robust Financials Driving The Recent Rally In Myers Industries, Inc.'s (NYSE:MYE) Stock?

Simply Wall St.

6 months ago

Are Robust Financials Driving The Recent Rally In Myers Industries, Inc.'s (NYSE:MYE) Stock?

Wall Street Analysts See a 67.76% Upside in Exscientia PLC Sponsored ADR (EXAI): Can the Stock Really Move This High?

Zacks

7 months ago

Wall Street Analysts See a 67.76% Upside in Exscientia PLC Sponsored ADR (EXAI): Can the Stock Really Move This High?

ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

GlobeNewswire

7 months ago

ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

With 65% ownership, Two Harbors Investment Corp. (NYSE:TWO) boasts of strong institutional backing

Simply Wall St.

7 months ago

With 65% ownership, Two Harbors Investment Corp. (NYSE:TWO) boasts of strong institutional backing

12 Most Promising Cancer Stocks According to Analysts

Insider Monkey

7 months ago

12 Most Promising Cancer Stocks According to Analysts

Stock Yards Bancorp Inc's Dividend Analysis

GuruFocus.com

7 months ago

Stock Yards Bancorp Inc's Dividend Analysis

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

PR Newswire

7 months ago

Cohen & Steers Closed-End Funds Declare Distributions for January, February, and March 2024

Business Wire

7 months ago

Community Trust Bancorp, Inc. Announces Retirement of James J. Gartner

Sphere Stock Gets an Upgrade After an Ugly Day

Barrons.com

7 months ago

Sphere Stock Gets an Upgrade After an Ugly Day

Genesis Energy, L.P. to Participate in the 2023 Wells Fargo Midstream & Utilities Symposium

Business Wire

7 months ago

Genesis Energy, L.P. to Participate in the 2023 Wells Fargo Midstream & Utilities Symposium

Tidewater Utilities Announces Promotion

GlobeNewswire

7 months ago

Tidewater Utilities Announces Promotion

ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

GlobeNewswire

7 months ago

ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Calumet Specialty Products Partners LP Earnings Call

ACCESSWIRE

8 months ago

Loma Negra 3Q23

Top Dividend Stocks: A Sizzling 8.8% Yield Highlights This Commercial REIT

Investor's Business Daily

8 months ago

Top Dividend Stocks: A Sizzling 8.8% Yield Highlights This Commercial REIT

Is Now An Opportune Moment To Examine Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA)?

Simply Wall St.

8 months ago

Is Now An Opportune Moment To Examine Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA)?

GuruFocus.com

8 months ago

Acelyrin Inc (SLRN) Reports Q3 2023 Financial Results: Key Clinical Trials Progressing

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

GlobeNewswire

8 months ago

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

Share on Social Networks: